Nano Mobile Healthcare, Inc. engages in the development of detection devices. The company is headquartered in Boston, Massachusetts and currently employs 3 full-time employees. The company went IPO on 2011-02-23. The Company’s first products are the convergence of nano-electronics, bio-informatics, and wireless technology. The products are based on patented technology invented by the National Aeronautics and Space Administration (NASA), which is license to Nanobeak, and further sub-licensed to the Company. The firm is focused on its screening for the presence of disease or the use of drugs.